August 26, 2019Open Access

Human Herpesvirus 6B and Lower Respiratory Tract Disease After Hematopoietic Cell Transplantation

JHJoshua A. HillFred Hutch Cancer Center LVLisa K. Vande VusseUniversity of Washington HXHu XieChina Three Gorges University

Key Points

Key points are not available for this paper at this time.

Abstract

These data provide evidence that HHV-6B detection in BALF is associated with higher mortality in allogeneic hematopoietic cell transplantation recipients with LRTD. Definitive evidence of causation will require a randomized prevention or treatment trial.

KI fragen

Bookmark

View Full Paper

Cite This Study

Hill et al. (Mon,) studied this question.

synapsesocial.com/papers/69b4b07b6cc839aa5eb3f55a https://doi.org/https://doi.org/10.1200/jco.19.00908

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation2010 · 1,482 citations
2Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia2001 · 17 citations
3Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation2003 · 269 citations
4Human Herpesvirus 6 (HHV-6) Reactivation and HHV-6 Encephalitis After Allogeneic Hematopoietic Cell Transplantation: A Multicenter, Prospective Study2013 · 195 citations
5Diagnostic Bronchoscopy in Solid-Organ and Hematopoietic Stem Cell Transplantation2013 · 57 citations

KI fragen

Bookmark

View Full Paper